Cipla
See the following -
"Industry Will Not Support Open-Ended Science, So Govt Must"
On December 11, News18 exposed how India’s clinical trials and drug discovery process is skewed towards diseases like cancer while ignoring the top killers of the country like TB, diarrhea and Kala Azar. Responding to that, Dr. Soumya Swaminathan, Director-General of the Indian Council for Medical Research (ICMR) told News18 there was a need to support indigenous research in India. In this interview to News18’s Aradhna Wal, Dr Swaminathan says India needs a 10-year vision on drug research...
- Login to post comments
Open Source Pharma And Prizes
I’m involved in a meeting happening next month in Italy that is asking “Can we develop a new open source pharmaceutical industry?” We’ll be talking amongst other things about incentives (such as prizes) and new ideas for the structure of pharma (legal and economic) and trying to come up with some pilot projects.
- Login to post comments